The Deep Brain Stimulation Devices Market size is expected to grow at an annual average of 10% during 2021-2027. Deep brain stimulation (DBS) is a neurosurgical procedure involving the implantation of a medical device called a neurostimulator (sometimes referred to as a ‘brain pacemaker’), which sends electrical impulses, through implanted electrodes, to specific targets in the brain (brain nuclei) for the treatment of movement and neuropsychiatric disorders. DBS in select brain regions has provided therapeutic benefits for otherwise-treatment-resistant disorders such as Parkinson’s disease, essential tremor, dystonia, chronic pain, major depression and obsessive–compulsive disorder (OCD). Despite the long history of DBS, its underlying principles and mechanisms are still not clear
(Get 15% Discount on Buying this Report)
A full report of Deep Brain Stimulation Devices Market is available at: https://www.orionmarketreports.com/deep-brain-stimulation-devices-market/28395/
The following segmentation are covered in this report:
By Type
- Single-channel DBS
- Dual Channel DBS
By Application
- Parkinson’s Disease
- Essential Tremor
- Dystonia
- Others
Company Profile
- Medtronic
- Boston Scientific
- Abbott
- Beijing Pins
- SceneRay
The report covers the following objectives:
- Proliferation and maturation of trade in the global Deep Brain Stimulation Devices Market
- The market share of the global Deep Brain Stimulation Devices Market supply and demand ratio, growth revenue, supply chain analysis, and business overview.
- Current and future market trends that are influencing the growth opportunities and growth rate of the Deep Brain Stimulation Devices Market
- Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Deep Brain Stimulation Devices Market
(This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.)
